Screener
Artiva Biotherapeutics, Inc. ARTV Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Artiva Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: Artiva Biotherapeutics, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:12 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338029
FAQ
- What is Artiva Biotherapeutics, Inc.'s net income?
- Artiva Biotherapeutics, Inc. (ARTV) reported net income of -$25.01M in Q2 2026.
- How has Artiva Biotherapeutics, Inc.'s net income changed year-over-year?
- Artiva Biotherapeutics, Inc.'s net income decreased by 17.6% year-over-year, from -$21.25M to -$25.01M.
- What is the long-term trend for Artiva Biotherapeutics, Inc.'s net income?
- Over 2 years (2023 to 2025), Artiva Biotherapeutics, Inc.'s net income has grown at a 70.9% compound annual growth rate (CAGR), from -$28.72M to -$83.87M.
- What does net income mean?
- Net income as the starting point for the indirect method operating cash flow reconciliation.
Ask your AI about Artiva Biotherapeutics, Inc.'s net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude